Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 7;101(3):478-484.
doi: 10.1016/j.ajhg.2017.08.004. Epub 2017 Aug 31.

Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes

Stefan H Lelieveld  1 , Laurens Wiel  2 , Hanka Venselaar  3 , Rolph Pfundt  4 , Gerrit Vriend  3 , Joris A Veltman  5 , Han G Brunner  6 , Lisenka E L M Vissers  4 , Christian Gilissen  7
Affiliations

Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes

Stefan H Lelieveld et al. Am J Hum Genet. .

Abstract

Haploinsufficiency (HI) is the best characterized mechanism through which dominant mutations exert their effect and cause disease. Non-haploinsufficiency (NHI) mechanisms, such as gain-of-function and dominant-negative mechanisms, are often characterized by the spatial clustering of mutations, thereby affecting only particular regions or base pairs of a gene. Variants leading to haploinsufficency might occasionally cluster as well, for example in critical domains, but such clustering is on the whole less pronounced with mutations often spread throughout the gene. Here we exploit this property and develop a method to specifically identify genes with significant spatial clustering patterns of de novo mutations in large cohorts. We apply our method to a dataset of 4,061 de novo missense mutations from published exome studies of trios with intellectual disability and developmental disorders (ID/DD) and successfully identify 15 genes with clustering mutations, including 12 genes for which mutations are known to cause neurodevelopmental disorders. For 11 out of these 12, NHI mutation mechanisms have been reported. Additionally, we identify three candidate ID/DD-associated genes of which two have an established role in neuronal processes. We further observe a higher intolerance to normal genetic variation of the identified genes compared to known genes for which mutations lead to HI. Finally, 3D modeling of these mutations on their protein structures shows that 81% of the observed mutations are unlikely to affect the overall structural integrity and that they therefore most likely act through a mechanism other than HI.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Examples of Identified Genes with Clustering Mutations Protein domains are annotated based on Pfam HMM search. cDNA locations of de novo missense mutations are depicted by blue pins. Genes shown here are as follows: SMAD4 (A), CDK13 (B), PACS2 (C). Figures visualizing the clustering of de novo missense mutations in the other 12 genes are provided in Figures S1–S15.
Figure 2
Figure 2
Intolerance to Missense Variation Violin plots show the distribution of the gene-based dN/dS (y axis) per gene set (x axis). The median dN/dS is indicated by a red horizontal line. The NHI genes are more intolerant to missense variation than HI genes (HI genes median: 0.460; NHI genes median: 0.428; p = 2.24e-03). In addition, the identified genes with clustering mutations are more intolerant to missense variation than HI genes (genes with clustering mutations median: 0.352; p = 8.45e-03).
Figure 3
Figure 3
Examples of Modeling of Missense Mutations on 3D Protein Structures Wild-type residues are marked in blue; de novo mutations are indicated as red globes or lines (Tables S17). (A) 3D structure of GNA1, acting through HI, showing that the modeled missense mutations are buried and likely to disrupt protein folding. (B) Structure of PPP2R5D, acting through NHI, where the modeled missense mutations affect mostly surface residues and are expected to have no or only local structural effects. (C) Zoom-in of known missense variants p.Arg496Cys and p.Ile500Val in SMAD4 known to act through a gain-of-function mechanism. These variants are located on the surface of the monomer and in contact with another SMAD4 monomer. (D) Zoom-in of the missense variant p.Gly343Arg in ACTL6B which is located at the surface. The side-chain points toward the solvent, therefore the larger Arginine will fit. (E) Zoom-in of the missense variant p.Pro65Leu in PCGF2 close to the interaction site with other molecules.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy.
    Villar-Pazos S, Thomas L, Yang Y, Chen K, Lyles JB, Deitch BJ, Ochaba J, Ling K, Powers B, Gingras S, Kordasiewicz HB, Grubisha MJ, Huang YH, Thomas G. Villar-Pazos S, et al. Nat Commun. 2023 Oct 17;14(1):6547. doi: 10.1038/s41467-023-42176-8. Nat Commun. 2023. PMID: 37848409 Free PMC article.
  • ALS-Associated KIF5A Mutation Causes Locomotor Deficits Associated with Cytoplasmic Inclusions, Alterations of Neuromuscular Junctions, and Motor Neuron Loss.
    Soustelle L, Aimond F, López-Andrés C, Brugioti V, Raoul C, Layalle S. Soustelle L, et al. J Neurosci. 2023 Nov 22;43(47):8058-8072. doi: 10.1523/JNEUROSCI.0562-23.2023. J Neurosci. 2023. PMID: 37748861 Free PMC article.
  • SLC6A1 variant pathogenicity, molecular function and phenotype: a genetic and clinical analysis.
    Stefanski A, Pérez-Palma E, Brünger T, Montanucci L, Gati C, Klöckner C, Johannesen KM, Goodspeed K, Macnee M, Deng AT, Aledo-Serrano Á, Borovikov A, Kava M, Bouman AM, Hajianpour MJ, Pal DK, Engelen M, Hagebeuk EEO, Shinawi M, Heidlebaugh AR, Oetjens K, Hoffman TL, Striano P, Freed AS, Futtrup L, Balslev T, Abulí A, Danvoye L, Lederer D, Balci T, Nouri MN, Butler E, Drewes S, van Engelen K, Howell KB, Khoury J, May P, Trinidad M, Froelich S, Lemke JR, Tiller J, Freed AN, Kang JQ, Wuster A, Møller RS, Lal D. Stefanski A, et al. Brain. 2023 Dec 1;146(12):5198-5208. doi: 10.1093/brain/awad292. Brain. 2023. PMID: 37647852 Free PMC article.
  • Stretch-activated ion channel TMEM63B associates with developmental and epileptic encephalopathies and progressive neurodegeneration.
    Vetro A, Pelorosso C, Balestrini S, Masi A, Hambleton S, Argilli E, Conti V, Giubbolini S, Barrick R, Bergant G, Writzl K, Bijlsma EK, Brunet T, Cacheiro P, Mei D, Devlin A, Hoffer MJV, Machol K, Mannaioni G, Sakamoto M, Menezes MP, Courtin T, Sherr E, Parra R, Richardson R, Roscioli T, Scala M, von Stülpnagel C, Smedley D; TMEM63B collaborators; Genomics England Research Consortium; Torella A, Tohyama J, Koichihara R, Hamada K, Ogata K, Suzuki T, Sugie A, van der Smagt JJ, van Gassen K, Valence S, Vittery E, Malone S, Kato M, Matsumoto N, Ratto GM, Guerrini R. Vetro A, et al. Am J Hum Genet. 2023 Aug 3;110(8):1356-1376. doi: 10.1016/j.ajhg.2023.06.008. Epub 2023 Jul 7. Am J Hum Genet. 2023. PMID: 37421948 Free PMC article.
  • The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder.
    Rots D, Jakub TE, Keung C, Jackson A, Banka S, Pfundt R, de Vries BBA, van Jaarsveld RH, Hopman SMJ, van Binsbergen E, Valenzuela I, Hempel M, Bierhals T, Kortüm F, Lecoquierre F, Goldenberg A, Hertz JM, Andersen CB, Kibæk M, Prijoles EJ, Stevenson RE, Everman DB, Patterson WG, Meng L, Gijavanekar C, De Dios K, Lakhani S, Levy T, Wagner M, Wieczorek D, Benke PJ, Lopez Garcia MS, Perrier R, Sousa SB, Almeida PM, Simões MJ, Isidor B, Deb W, Schmanski AA, Abdul-Rahman O, Philippe C, Bruel AL, Faivre L, Vitobello A, Thauvin C, Smits JJ, Garavelli L, Caraffi SG, Peluso F, Davis-Keppen L, Platt D, Royer E, Leeuwen L, Sinnema M, Stegmann APA, Stumpel CTRM, Tiller GE, Bosch DGM, Potgieter ST, Joss S, Splitt M, Holden S, Prapa M, Foulds N, Douzgou S, Puura K, Waltes R, Chiocchetti AG, Freitag CM, Satterstrom FK, De Rubeis S, Buxbaum J, Gelb BD, Branko A, Kushima I, Howe J, Scherer SW, Arado A, Baldo C, Patat O, Bénédicte D, Lopergolo D, Santorelli FM, Haack TB, Dufke A, Bertrand M, Falb RJ, Rieß A, Krieg P, Spranger S, Bedeschi MF, Iascone M, Josephi-Taylor S, Roscioli T, Buckley MF, Liebelt J, Dagli AI, Aten E, Hurst ACE, Hicks A, Suri M, Aliu E, Naik S, Sidlow R, Coursimault J, Nicolas G… See abstract for full author list ➔ Rots D, et al. Am J Hum Genet. 2023 Jun 1;110(6):963-978. doi: 10.1016/j.ajhg.2023.04.008. Epub 2023 May 16. Am J Hum Genet. 2023. PMID: 37196654 Free PMC article.
See all "Cited by" articles

References

    1. The Deciphering Developmental Disorders Study Large-scale discovery of novel genetic causes of developmental disorders. Nature. 2015;519:223–228. - PMC - PubMed
    1. Gilissen C., Hehir-Kwa J.Y., Thung D.T., van de Vorst M., van Bon B.W., Willemsen M.H., Kwint M., Janssen I.M., Hoischen A., Schenck A. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344–347. - PubMed
    1. Srour M., Caron V., Pearson T., Nielsen S.B., Lévesque S., Delrue M.A., Becker T.A., Hamdan F.F., Kibar Z., Sattler S.G. Gain-of-Function Mutations in RARB Cause Intellectual Disability with Progressive Motor Impairment. Hum. Mutat. 2016;37:786–793. - PubMed
    1. Hoischen A., van Bon B.W., Gilissen C., Arts P., van Lier B., Steehouwer M., de Vries P., de Reuver R., Wieskamp N., Mortier G. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat. Genet. 2010;42:483–485. - PubMed
    1. Schuurs-Hoeijmakers J.H., Oh E.C., Vissers L.E., Swinkels M.E., Gilissen C., Willemsen M.A., Holvoet M., Steehouwer M., Veltman J.A., de Vries B.B. Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome. Am. J. Hum. Genet. 2012;91:1122–1127. - PMC - PubMed

Substances

LinkOut - more resources

-